Overview: EBV Qualitative PCR TestIntroduction: The EBV Qualitative PCR Test detects Epstein-Barr virus DNA, confirming active infection causing fatigue or sore throat. Aligned with 2023 IDSA guidelines, it uses PCR for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for patients with suspected active EBV infections.
Other Names: EBV Qual PCR Assay, Epstein-Barr Virus DNA Detection Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: EBV PCR testing began in the 1990s with molecular diagnostics. Qualitative PCR emerged in the 2000s, improving detection accuracy for active infections.
Purpose: Confirms active EBV infection, guides supportive care, and monitors viral DNA in patients with fatigue or sore throat.
Test Parameters: 1. Epstein-Barr Virus DNA
Pretest Condition: No fasting required. Collect whole blood, serum, plasma, CSF, or saliva at any time. Report symptoms like fatigue or sore throat, and list immunocompromising conditions.
Specimen: 2-5 mL whole blood (EDTA), 2-5 mL serum (SST), 2-4 mL plasma (EDTA), 1-2 mL CSF (sterile container), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, sore throat, or immunocompromised states (e.g., HIV, transplant). Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for supportive care.
Procedural Considerations: Uses qualitative PCR to detect EBV DNA. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Low viral load or improper storage can cause false negatives. Contamination may cause false positives.
Clinical Significance: Positive DNA results confirm active EBV infection, prompting supportive care. Negative results may require IgM or repeat testing.
Specialist Consultation: Consult an infectious disease specialist or hematologist for result interpretation.
Additional Supporting Tests: EBV VCA IgG/IgM, viral culture, or lymphocyte count to confirm infection status.
Test Limitations: False negatives may occur with low viral load. Results require clinical correlation.
References: IDSA EBV Guidelines, 2023; Clinical Infectious Diseases, Cohen JI, 2022.
